128 related articles for article (PubMed ID: 27925431)
1. Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin.
Chao CT; Huang JW; Chiang CK; Chen YC; Fang CC; Hu FC; Chang CC; Yen CJ
Nephrology (Carlton); 2018 Feb; 23(2):117-125. PubMed ID: 27925431
[TBL] [Abstract][Full Text] [Related]
2. Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients.
Chao CT; Chen YC; Chiang CK; Huang JW; Fang CC; Chang CC; Yen CJ
Oxid Med Cell Longev; 2016; 2016():8516748. PubMed ID: 26881045
[TBL] [Abstract][Full Text] [Related]
3. Association of
Jerotic D; Matic M; Suvakov S; Vucicevic K; Damjanovic T; Savic-Radojevic A; Pljesa-Ercegovac M; Coric V; Stefanovic A; Ivanisevic J; Jelic-Ivanovic Z; McClements L; Dimkovic N; Simic T
Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31340563
[TBL] [Abstract][Full Text] [Related]
4. Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses of patients with end-stage renal disease.
Chao CT; Chen YC; Chiang CK; Huang JW; Hu FC; Fang CC; Chang CC; Yen CJ
Dis Markers; 2015; 2015():763459. PubMed ID: 25784779
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy.
Yao Q; Nordfors L; Axelsson J; Heimbürger O; Qureshi AR; Báràny P; Lindholm B; Lönnqvist F; Schalling M; Stenvinkel P
Atherosclerosis; 2005 Sep; 182(1):105-11. PubMed ID: 16115480
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic variations in manganese superoxide dismutase (MnSOD), glutathione peroxidase-1 (GPX1), and catalase (CAT) contribute to elevated plasma triglyceride levels in Chinese patients with type 2 diabetes or diabetic cardiovascular disease.
Chen H; Yu M; Li M; Zhao R; Zhu Q; Zhou W; Lu M; Lu Y; Zheng T; Jiang J; Zhao W; Xiang K; Jia W; Liu L
Mol Cell Biochem; 2012 Apr; 363(1-2):85-91. PubMed ID: 22167619
[TBL] [Abstract][Full Text] [Related]
7. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
[TBL] [Abstract][Full Text] [Related]
8. Associations Between Genetic Polymorphisms in the
Luo Y; Luo J; Peng H
Genet Test Mol Biomarkers; 2019 Sep; 23(9):644-651. PubMed ID: 31524543
[No Abstract] [Full Text] [Related]
9. Evaluation of the oxidative stress-related genes ALOX5, ALOX5AP, GPX1, GPX3 and MPO for contribution to the risk of type 2 diabetes mellitus in the Han Chinese population.
Liu D; Liu L; Hu Z; Song Z; Wang Y; Chen Z
Diab Vasc Dis Res; 2018 Jul; 15(4):336-339. PubMed ID: 29383971
[TBL] [Abstract][Full Text] [Related]
10. Glutathione peroxidase-1 gene (GPX1) variants, oxidative stress and risk of kidney complications in people with type 1 diabetes.
Mohammedi K; Patente TA; Bellili-Muñoz N; Driss F; Le Nagard H; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
Metabolism; 2016 Feb; 65(2):12-9. PubMed ID: 26773925
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of superoxide dismutases, catalase, and glutathione peroxidase in age-related cataract.
Zhang Y; Zhang L; Sun D; Li Z; Wang L; Liu P
Mol Vis; 2011; 17():2325-32. PubMed ID: 21921984
[TBL] [Abstract][Full Text] [Related]
12. Association of Superoxide dismutases (SOD1 and SOD2) and Glutathione peroxidase 1 (GPx1) gene polymorphisms with type 2 diabetes mellitus.
Vats P; Sagar N; Singh TP; Banerjee M
Free Radic Res; 2015 Jan; 49(1):17-24. PubMed ID: 25283363
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of Antioxidant Enzymes SOD2 (rs4880) and GPX1 (rs1050450) Are Associated with Bladder Cancer Risk or Its Aggressiveness.
Nikic P; Dragicevic D; Jerotic D; Savic S; Djukic T; Stankovic B; Kovacevic L; Simic T; Matic M
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676755
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in peroxisome proliferator-activated receptor-γ and retinoid X receptor-α gene and type 2 diabetes risk: a case-control study of a Chinese Han population.
Lu Y; Ye X; Cao Y; Li Q; Yu X; Cheng J; Gao Y; Ma J; Du W; Zhou L
Diabetes Technol Ther; 2011 Feb; 13(2):157-64. PubMed ID: 21284483
[TBL] [Abstract][Full Text] [Related]
15. Association of RAC1 Gene Polymorphisms with Primary End-Stage Renal Disease in Chinese Renal Recipients.
Liu Y; Zhou J; Luo X; Yang C; Zhang Y; Shi S
PLoS One; 2016; 11(2):e0148270. PubMed ID: 26841219
[TBL] [Abstract][Full Text] [Related]
16. Interaction of antioxidant gene variants and susceptibility to type 2 diabetes mellitus.
Banerjee M; Vats P; Kushwah AS; Srivastava N
Br J Biomed Sci; 2019 Oct; 76(4):166-171. PubMed ID: 30900957
[No Abstract] [Full Text] [Related]
17. The relationship of the peroxisome proliferator-activated receptor-gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
Erdogan M; Karadeniz M; Eroglu Z; Tezcanli B; Selvi N; Yilmaz C
Diabetes Res Clin Pract; 2007 Dec; 78(3):355-9. PubMed ID: 17681394
[TBL] [Abstract][Full Text] [Related]
18. Effect of 593C>T GPx1 SNP alone and in synergy with 47C>T SOD2 SNP on the outcome of critically ill patients.
Majolo F; Oliveira Paludo FJ; Ponzoni A; Graebin P; Dias FS; Alho CS
Cytokine; 2015 Feb; 71(2):312-7. PubMed ID: 25497738
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Peroxisome Proliferator-Activated Receptor Gamma and Its Interaction with Abdominal Obesity on Diabetic Nephropathy in Chinese Han.
Zhang M; Yuan H; Li C; Li C
Nephron; 2017; 135(3):224-230. PubMed ID: 28013303
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleotide polymorphisms of peroxisome proliferator-activated receptor-γ are associated with systemic lupus erythematosus in a Chinese Han population.
Ren DF; Zhang J
Clin Exp Dermatol; 2016 Jul; 41(5):541-6. PubMed ID: 27324555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
